Physician
Mora-Mclaughlin, Fernando
Mora-Mclaughlin, Fernando was paid $1.96M by Medicaid between Jan 2018 and Nov 2024, across 76 billing codes. Its largest line is 87633, Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets — 43% of everything it billed.
33Billing provider infoMORA-MCLAUGHLIN, FERNANDO
BRONX, NY 10452
BRONX, NY 10452
33aNPI1942381405assigned 10/18/2006
33bProvider typeInternal Medicine Physician
28Total paid$1.96M
24GClaims123,826
24DCodes billed76
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Internal Medicine Physician providers in New York
Rank by total paid#137 of 6,049
Median peer was paid$11K
This provider vs. median174×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,398 | $106K | |
| 2019 | 14,110 | $167K | |
| 2020 | 14,615 | $309K | |
| 2021 | 14,623 | $385K | |
| 2022 | 15,560 | $324K | |
| 2023 | 29,317 | $434K | |
| 2024incomplete | 30,203 | $238K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 43% | 2,218 | 2,121 | $840K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 30% | 13,268 | 8,833 | $595K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 7.1% | 3,375 | 3,001 | $140K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 4.3% | 987 | 953 | $85K |
| 80305 | 2.3% | 3,818 | 3,560 | $45K | |
| 82947 | 2.0% | 10,843 | 6,923 | $38K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.5% | 429 | 390 | $30K |
| H0001 | Alcohol and/or drug assessment | 1.4% | 3,851 | 3,639 | $27K |
| 94060 | <1% | 435 | 430 | $18K | |
| 93000 | <1% | 1,112 | 1,091 | $13K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,444 | 1,329 | $11K |
| 99606 | <1% | 1,047 | 870 | $9K |
64 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 4,679 | $9K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 214 | $7K |
| G0270 | Medical nutrition therapy; reassessment and subsequent intervention(s) following second referral in same year for change in diagnosis, medical condition or treatment regimen (including additional hours needed for renal disease), individual, face to face with the patient, each 15 minutes | <1% | 995 | $7K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 577 | $7K |
| 92081 | <1% | 287 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 821 | $6K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 103 | $5K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | <1% | 4,084 | $5K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 221 | $5K |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 1,029 | $4K |
| 96116 | <1% | 164 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 69 | $4K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 363 | $4K |
| 86359 | <1% | 74 | $3K | |
| 90756 | <1% | 140 | $3K | |
| 81002 | <1% | 3,111 | $3K | |
| 90732 | <1% | 25 | $2K | |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | <1% | 185 | $2K |
| 87534 | <1% | 93 | $2K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 363 | $2K |
| 3078F | <1% | 6,036 | $2K | |
| 94644 | <1% | 46 | $2K | |
| 3074F | <1% | 5,867 | $2K | |
| G0445 | High intensity behavioral counseling to prevent sexually transmitted infection; face-to-face, individual, includes: education, skills training and guidance on how to change sexual behavior; performed semi-annually, 30 minutes | <1% | 391 | $2K |
| 99407 | <1% | 127 | $2K | |
| G0444 | Annual depression screening, 5 to 15 minutes | <1% | 353 | $2K |
| 99386 | <1% | 94 | $1K | |
| 99385 | <1% | 75 | $1K | |
| 97802 | <1% | 732 | $1K | |
| 90688 | <1% | 59 | $1K | |
| 80061 | Lipid panel | <1% | 110 | $888.23 |
| G0008 | Administration of influenza virus vaccine | <1% | 118 | $338.55 |
| 99441 | <1% | 17 | $333.24 | |
| 36416 | <1% | 5,672 | $308.83 | |
| 99454 | <1% | 84 | $290.41 | |
| 1159F | <1% | 11,387 | $290.00 | |
| 81000 | <1% | 309 | $274.24 | |
| 99000 | <1% | 2,879 | $242.57 | |
| 99457 | <1% | 58 | $226.80 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 43 | $204.79 |
| 90658 | <1% | 59 | $163.65 | |
| G9507 | Documentation that the patient is on a statin medication or has documentation of a valid contraindication or exception to statin medications; contraindications/exceptions that can be defined by diagnosis codes include pregnancy during the measurement period, active liver disease, rhabdomyolysis, end stage renal disease on dialysis and heart failure; provider documented contraindications/exceptions include breastfeeding during the measurement period, woman of child-bearing age not actively taking birth control, allergy to statin, drug interaction (hiv protease inhibitors, nefazodone, cyclosporine, gemfibrozil, and danazol) and intolerance (with supporting documentation of trying a statin at least once within the last 5 years or diagnosis codes for myostitis or toxic myopathy related to drugs) | <1% | 890 | $131.70 |
| 99401 | <1% | 278 | $129.80 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 35 | $91.52 |
| G9797 | Patient is not on a high intensity statin therapy | <1% | 2,701 | $75.00 |
| 99458 | <1% | 14 | $46.31 | |
| 3075F | <1% | 183 | $42.50 | |
| 82465 | <1% | 64 | $30.18 | |
| 1125F | <1% | 3,859 | $25.00 | |
| 83721 | <1% | 65 | $14.27 | |
| 1160F | <1% | 1,338 | $12.50 | |
| 3079F | <1% | 13 | $10.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 384 | $0.01 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 13,291 | $0.00 |
| 0518F | 0% | 260 | $0.00 | |
| 3725F | 0% | 386 | $0.00 | |
| 1003F | 0% | 650 | $0.00 | |
| 99408 | 0% | 15 | $0.00 | |
| G8482 | Influenza immunization administered or previously received | 0% | 57 | $0.00 |
| G9664 | Patients who are currently statin therapy users or received an order (prescription) for statin therapy | 0% | 2,107 | $0.00 |
| 3014F | 0% | 164 | $0.00 | |
| 3044F | 0% | 1,416 | $0.00 | |
| 3017F | 0% | 264 | $0.00 | |
| 1170F | 0% | 452 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.